FDA Grants Full Approval for Moderna Vaccine

January 31, 2022 by Alexa Hornbeck
FDA Grants Full Approval for Moderna Vaccine
A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore., Monday, Dec. 27, 2021. (AP Photo/Jenny Kane)

WASHINGTON — The U.S. Food and Drug Administration has approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine, known as Spikevax, was approved after finding the vaccine met rigorous standards for safety, effectiveness, and manufacturing quality.

“The FDA’s approval of Spikevax is a significant step in the fight against the COVID-19 pandemic, marking the second vaccine approved to prevent COVID-19,” said Acting FDA Commissioner Janet Woodcock, in a press release.

In 2020, the FDA approved the Moderna COVID-19 vaccine for use in individuals 18 years of age or older under an emergency use authorization.

Spikevax, which uses the same formulation of the EUA Moderna COVID-19 vaccine, will be administered through a series of two doses, each a month apart.

For those 18 years of age or older, Spikevax can be used interchangeably with the EUA Moderna COVID-19 vaccine to complete a vaccine series of three doses, or it can be used to mix and match as a single booster at least five months after a completed series of a different available COVID-19 vaccine.

“While hundreds of millions of doses of Moderna COVID-19 vaccine have been administered to individuals under emergency use authorization, we understand that for some individuals, FDA approval of this vaccine may instill additional confidence in making the decision to get vaccinated,” said Woodcock.

The clinical trial to determine effectiveness and safety of Spikevax was built upon the data and information which supported the EUA for the Moderna COVID-19 vaccine.

To conduct the trial, researchers enrolled 14,287 recipients 18 years of age and older to receive the vaccine and 14,164 recipients received a placebo.

The results showed that Spikevax was 93% effective in preventing severe disease after a clinical trial, with only 55 cases of COVID-19 occurring in the vaccine group compared to 744 cases in the placebo group.

The vaccine was also found to be 98% effective in preventing severe disease.

A separate evaluation for safety was conducted involving 15,184 vaccine recipients and 15,162 placebo recipients who were 18 years of age and older. More than half of the participants were then followed for four months after the second dose.

Additionally, an extra level of surveillance was conducted pertaining to inflammation of the heart muscle and inflammation of the tissue surrounding the heart which showed that there is an increase in these risks particularly within seven days following the second dose of Spikevax.

The highest observed risk was in males ages 18 to 24 years of age, but short-term follow-up data suggests that most individuals had a resolution of symptoms.

Still, the FDA has advised not enough information about Spikevax is available to fully understand the potential long-term health outcomes.

Alexa can be reached at [email protected]

 

A+
a-
  • COVID-19
  • Food and Drug Administration
  • Moderna COVID-19 vaccine
  • Spikevax
  • In The News

    Health

    Voting

    In The News

    March 28, 2024
    by Dan McCue
    Silicon Valley-Based Firm Launches ‘Radar as a Service’

    BELMONT, Calif. — At first the idea sounds about as un-Silicon Valley as one can get. After all, the basic... Read More

    BELMONT, Calif. — At first the idea sounds about as un-Silicon Valley as one can get. After all, the basic concept underlying radar was proven in 1886, when a German physicist named Heinrich Hertz showed that radio waves could be reflected from solid objects. And the... Read More

    March 28, 2024
    by Dan McCue
    Elections Task Force Prosecutes 2020 ‘Vigilantes,’ Seeks More Civic Dialogue

    PHOENIX, Ariz. — A 46-year-old Ohio man has been sentenced to 30 months in prison for sending death threats to... Read More

    PHOENIX, Ariz. — A 46-year-old Ohio man has been sentenced to 30 months in prison for sending death threats to an Arizona election official. The sentencing of Joshua Russell, of Bucyrus, Ohio, came after he pleaded guilty to one count of making a threatening interstate communication.... Read More

    March 28, 2024
    by Tom Ramstack
    Disney World Settles with Florida After Its Opposition to 'Don’t Say Gay' Law

    ORLANDO — The company that runs Walt Disney World reached a settlement Wednesday with appointees of Florida Gov. Ron DeSantis... Read More

    ORLANDO — The company that runs Walt Disney World reached a settlement Wednesday with appointees of Florida Gov. Ron DeSantis who were exerting controversial regulatory control over the huge tourism complex. The settlement resolves some of the disputes that arose after Disney officials publicly denounced the... Read More

    US Changes How It Categorizes People by Race and Ethnicity. It's the First Revision in 27 Years

    ORLANDO, Fla. (AP) — For the first time in 27 years, the U.S. government is changing how it categorizes people by race and... Read More

    ORLANDO, Fla. (AP) — For the first time in 27 years, the U.S. government is changing how it categorizes people by race and ethnicity, an effort that federal officials believe will more accurately count residents who identify as Hispanic and of Middle Eastern and North African heritage. The revisions... Read More

    March 28, 2024
    by Dan McCue
    Vice President Harris Rolls Out First Government-Wide Policy to Mitigate AI Risks

    WASHINGTON — Vice President Kamala Harris on Wednesday rolled out the Biden administration’s first government-wide policy intended to mitigate the... Read More

    WASHINGTON — Vice President Kamala Harris on Wednesday rolled out the Biden administration’s first government-wide policy intended to mitigate the risks associated with artificial intelligence while still enabling its use to advance the public interest. The new policy, which is being issued through the White House... Read More

    March 27, 2024
    by TWN Staff
    Rep. Cleaver New Co-Chair of House Renewable Energy and Energy Efficiency Caucus

    WASHINGTON — Rep. Emanuel Cleaver II, D-Mo., is the new Democratic co-chair of the House Renewable Energy and Energy Efficiency... Read More

    WASHINGTON — Rep. Emanuel Cleaver II, D-Mo., is the new Democratic co-chair of the House Renewable Energy and Energy Efficiency Caucus. He was invited to serve as co-chair by Sens. Jack Reed, D-R.I., and Mike Crapo, R-Idaho, the co-chairs of the Senate Renewable Energy and Energy... Read More

    News From The Well
    scroll top